In 2022, the national medical insurance catalogue will be adjusted to drugs that have passed the preliminary form review

In accordance with the "2022 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue Adjustment Work Plan" and the "2022 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue Adjustment Declaration Guide", our bureau organized forces to conduct a preliminary formal review
of the drug declaration materials for the adjustment of the medical insurance drug catalogue in 2022.
Drugs and related information that will pass the preliminary formal examination are hereby announced
.
Passing the formal review is not equivalent to being included in the national medical insurance drug list, and it is also necessary to carry out expert review, negotiation and bidding in accordance with the
procedures.
The publicity period is from September 6, 2022 to September 12, 2022 (one week).

During the publicity period, all sectors of society are invited to supervise
the qualification conditions, relevant information and preliminary form examination results of the publicized drugs.
If you have any comments and suggestions, please reflect
them to the special class of the National Medical Insurance Bureau in the form of fax, letter or mail during the publicity period.
For the convenience of verification, please sign your real name for the feedback and attach relevant supporting materials
.
Email: YBML001@nhsa.
gov.
cn (the email name is "2022 National Medical Insurance Drug Catalog Form Review Opinions", and please indicate the contact person and telephone) Fax: 010-89061364 Address: Room 120, No.
2-9, Yuetan North Street, Xicheng District, Beijing Medical Insurance Bureau Catalogue Adjustment Work Class (Zip Code: 100830) Attachments: 1.
2022 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue Adjustment The List of Declared Drugs Approved by Preliminary Formal Examination 2.
2022 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue Adjustment Declared Drug Information through Preliminary Formal Examination National Medical Security Bureau September 6, 2022 Drugs 2022 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue Adjustment The List of Declared Drugs Approved by Preliminary Form Review2022 National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog Adjustment Passed by Preliminary Form Review The List of Declared Drugs 2022 The National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue Adjustment Through preliminary form review Of declared drug information 2022 National Basic Medical Insurance, Adjustment of the catalogue of work-related injury insurance and maternity insurance drugs has passed the preliminary form review of the declared drug information